Research Center: Hanson Clinical Research Center
Location: 21216 Olean Blvd., suite 6, Port Charlotte, Florida, United States
Lead Researcher: Lenita Hanson, M.D.
IRB: This study has been reviewed and approved by the Advarra Institutional Review Board

Low blood sugar (hypoglycemia) is a common challenge for people with type 1 diabetes, especially at night. Unfortunately, current treatments don’t always effectively prevent these episodes.

ZT-01 is an experimental drug designed to help boost glucagon production during low blood sugar events. Researchers from Hanson Clinical Research Center are investigating whether ZT-01 can reduce nocturnal hypoglycemia and improve overall management of type 1 diabetes. Sign up today to see if you qualify and be part of this exciting study!

• Participants may receive a new potential treatment at no cost.
• Participants will be compensated up to $525 for participating in this study. 
• Participants will be contributing valuable information that may benefit those with type 1 diabetes in the future.
• Participants will be helping to advance medical research.

• If you decide to participate in the study and later feel that you no longer wish to be part of it, you can withdraw at any time.
• Any information that you provide will be kept strictly confidential, except as required by law.
• Qualified health professionals will monitor your health as it relates to the study.

• Men and women aged 18+ who have been diagnosed with type 1 diabetes for at least 5 years
• Must have a BMI between 18.5 and 33 kg/m² 
• Must have either experienced symptoms of low blood sugar (such as sweating, shakiness, confusion, or waking up feeling unwell) during the night within the past 4 weeks or have CGM time below range not meeting the target
• Must have an HbA1c test result of 10% or less
• Must not have been hospitalized more than once due to diabetic ketoacidosis (DKA) in the last 6 months
• Must not have experienced at least one episode of severe hypoglycemia that required assistance from another person in the past 4 weeks
• Must not have experienced two or more episodes of severe hypoglycemia requiring assistance in the past 3 months
• Must be able and willing to participate in the study and complete all required procedures

The study team will explain the research in its entirety but some details are:

• Participants will be asked to sign an informed consent form and undergo screening tests to determine if they meet the study criteria.
• Participants will be asked to provide general information about their age, sex, race, and ethnicity, along with their medical and medication history.
• Participants will be asked to complete various tests, including a physical examination, blood pressure and pulse measurements, and urine and blood tests for a variety of health checks.

Hanson Clinical Research Center
Established in 2012, Hanson Clinical Research Center is a leading institution dedicated to advancing medical knowledge and improving patient care. They specialize in diabetes, kidney, cardiovascular, and thyroid conditions and conduct phases 2, 3, and 4 trials to evaluate the safety and efficacy of innovative treatments.